The Global Market for Cell Surface Markers Identification Equipment is Projected to Reach US$4.8 Billion by 2020
Robust Investments in Drug
Discovery to Drive the Cell Surface Markers Identification Market, According to
a New Report by Global Industry Analysts, Inc.
GIA
launches comprehensive analysis of industry segments, trends, growth drivers,
market share, size and demand forecasts on the global Cell Surface Markers
Identification market. The global market for Cell
Surface Markers Identification Equipment is projected to reach US$4.8 billion
by 2020,
driven by the robustly growing investments in drug discovery and increasing
demand for advanced diagnostic and laboratory equipment.
Cell
surface markers, defined as proteins/antigens expressed on the surface of
cells, are useful tools in identification and categorization of cells. Offering
efficient capabilities in immunophenotyping, cell surface markers offer
important insights on various stages and pathways of cell differentiation that
have relevance in diagnosis and treatment of diseases. These proteins play an important role in understanding pathophysiological
conditions such as autoimmunity, identification
of stem cells, and characterization of their phenotypes for further
experimental studies. Drug discovery research constitutes a major application of cell
surface markers. Cell surface marker analysis facilitates researchers to
evaluate the efficacy of a drug and its impact on patient’s condition. Other exciting
areas include personalized medicine wherein analysis and understanding of cells
isolated from patients and their response to therapy would allow the physician
to make safer and effective medical decisions.
As
cell level analysis relies on cell surface markers, many of drug discovery
programs use cell surface marker identification instruments and reagents for
evaluating the effectiveness of the drug in controlling a disease. The market has
been exhibiting noticeable growth over the past few years, driven by the surge
in healthcare and drug discovery research. Increased focus on lab automation is another major factor
generating substantial demand for markers identification equipment. Cell
surface markers detection equipment is widely used in research applications
including cytological academic research and drug discovery programs. Growing
prevalence of chronic disorders such as cancer and autoimmune diseases and
increased need to address the medical needs of the spiraling number of patients
through sophisticated and reliable technology solutions is creating a favorable
environment for growth in the healthcare and life sciences sectors.
Flow cytometers are widely used for cell
surface markers identification, accounting for over 2/3rd share of the total
market. Flowcytometric analysis is extensively used in characterization of
cells. Technological advancements and the resulting improvements in terms of
accuracy, precision and speed have expanded flow cytometry applications in
cellular analysis, genomic and molecular analysis, and measurement of a variety
of soluble and intracellular proteins such as cell signaling pathways, cytokines,
and growth factors. High-throughput flow cytometry is used for performing
multiplexed cell-based and bead-based screenings.
As
stated by the new market research report on Cell Surface Markers
Identification,
the United States constitutes the largest market worldwide. Asia-Pacific ranks
as the fastest growing market, with a CAGR of over 12.4% over the analysis
period, led by growing healthcare and research expenditure, move towards
laboratory automation, increased access to healthcare, and proliferation of
medical tourism.
Major
players covered in the report include Abbott Laboratories, BD Biosciences,
Beckman Coulter, Bio-Rad Laboratories, CellaVision AB, Dako Denmark A/S, eBioscience,
EMD Millipore, F. Hoffmann-La Roche, Grifols, S.A, Horiba, Mindray Medical
International, Ortho-Clinical Diagnostics, QIAGEN N.V., Siemens Healthcare, Sysmex
Corporation, and Thermo Fisher Scientific, among others.
The research report titled “Cell Surface Markers
Identification: A Global Strategic Business Report” announced by Global
Industry Analysts Inc., provides a comprehensive
review of market trends, issues, drivers, mergers, acquisitions and other
strategic industry activities of global companies. The report provides market
estimates and projections in US$ Million for all major geographic markets such
as the US, Canada, Japan, Europe, Asia-Pacific (China, India, and Rest of
Asia-Pacific), Latin America, and Rest of World. The report also analyzes the
global market for Cell Surface Markers Identification Equipment by segment – Flow
Cytometers and Others (Includes Hematology Analyzers, Reagents, and Kits).
Comments
Post a Comment